A consensus has emerged among experts who study and treat long Covid: Paxlovid seems to reduce the risk of lingering symptoms among those eligible to take it. The idea is intuitive, experts say.

Since 2020, the condition known as long COVID-19 has become a widespread disability affecting the health and quality of life of millions of people across the globe and costing economies billions of ...

The #CoronavirusFacts database records fact-checks published since the beginning of the COVID-19 outbreak. The pandemic and its consequences are constantly evolving and data that was accurate weeks or ...

Yearly Covid-19 Booster Recommendations in Canada, Europe, and Australia. Although the rapid development of multiple Covid-19 vaccines in 2020 represents a major scientific, medical, and regulatory ...